Moreover, the persistence of defective FAS-mediated apoptosis in both lymphoid cells and tumor tissues evidences the role of impaired apoptotic pathways as a key factor in lymphomagenesis, justifying the clinical follow-up of asymptomatic carriers of FAS variants (35, 36). Here, FAS is linked to neoplasm.